Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Community-Acquired Pneumonia: An Overview.

Kanno1, Brown

  • 1Division of Infectious Diseases, Department of Internal Medicine, Wayne State University School of Medicine/Detroit Medical Center; and Harper Hospital, 4 Yellow Center, 3990 John R., Detroit, MI 48201, USA.

Current Infectious Disease Reports
|November 30, 2000
PubMed
Summary

Community-acquired pneumonia (CAP) is a major cause of illness and death, especially in older adults. Current guidelines emphasize pathogen-specific treatment, but more data is needed to assess the impact of these approaches on care quality and cost.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Positions and Intensities in the 2nu4/nu1/nu3 Vibrational System of 14NH3 Near 3 µm.

Journal of molecular spectroscopy·1999
Same author

Proximate and ultimate causes of adoption in ring-billed gulls.

Animal behaviour·1999
Same author

Research: The Effect of Wetland Mitigation Banking on the Achievement of No-Net-Loss.

Environmental management·1999
Same author

Response

Gastrointestinal endoscopy·1999
Same author

Manipulation of in vivo sorbitol production alters boron uptake and transport in tobacco

Plant physiology·1999
Same author

Biochemical analysis of plant protection afforded by a nonpathogenic endophytic mutant of colletotrichum magna

Plant physiology·1999

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Background:

  • Community-acquired pneumonia (CAP) represents a significant burden on healthcare systems, leading to numerous hospitalizations, outpatient visits, and substantial costs.
  • The elderly population is disproportionately affected, accounting for over 90% of pneumonia-related fatalities.
  • While Streptococcus pneumoniae is traditionally considered the primary pathogen, atypical pathogens are increasingly recognized, particularly in ambulatory patients.

Purpose of the Study:

  • To review current understanding of CAP etiology, risk factors, and mortality.
  • To examine the impact of antimicrobial resistance on empiric CAP therapy.
  • To evaluate the role and effectiveness of recent practice guidelines in managing CAP.

Main Methods:

Related Experiment Videos

  • Literature review of recent studies on CAP epidemiology, treatment, and outcomes.
  • Analysis of data concerning mortality risk and process of care in CAP patients.
  • Examination of the implications of increasing Streptococcus pneumoniae resistance on therapeutic strategies.

Main Results:

  • Emerging evidence suggests atypical pathogens may be more prevalent than previously assumed in CAP.
  • Increasing antimicrobial resistance in Streptococcus pneumoniae necessitates adjustments in empiric treatment protocols.
  • Recent guidelines advocate for pathogen-specific therapy, guided by diagnostic tests like sputum Gram stain and culture.

Conclusions:

  • Despite the development of practice guidelines for CAP management, robust data on their impact on healthcare quality and cost is still lacking.
  • Further research is required to ascertain the real-world effectiveness of guideline-driven interventions for CAP.
  • The evolving landscape of CAP pathogens and antimicrobial resistance underscores the need for adaptive management strategies.